Trials / Conditions / Cholangiocellular Carcinoma

Cholangiocellular Carcinoma

7 registered clinical trials studyying Cholangiocellular Carcinoma.

Status	Trial	Sponsor	Phase
Completed	A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor NCT02999672	Hoffmann-La Roche	Phase 2
Completed	Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors NCT02156700	University Hospital Dubrava	—
Completed	Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcita NCT01862315	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy NCT01692704	University of Zurich	Phase 1 / Phase 2
Completed	Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Str NCT01320241	Southeast University, China	Phase 2
Completed	Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. NCT01073839	University of Zurich	Phase 1 / Phase 2
Terminated	Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers NCT00832637	New Mexico Cancer Research Alliance	Phase 2